Jim Simons
INAB icon

Jim Simons’s IN8bio INAB Stock Holding History

Jim Simons’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,972
Closed -$141K – 3719
2024
Q1 		$141K Buy
3,972
+3,319
+508% +$125K ﹤0.01% 3299
2023
Q4 		$27K Buy
+653
New +$20.9K ﹤0.01% 3546
2023
Q3 		– Sell
-723
Closed -$33K – 3873
2023
Q2 		$33K Buy
+723
New +$45.2K ﹤0.01% 3686

Other funds holding INAB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Jim Simons's INAB Position: Q2 2024 in Review

Jim Simons sold out of IN8bio (INAB) in Q2 2024, closing a stake of 3,972 shares — an estimated $141K sold.

Jim Simons first reported a position in INAB in Q2 2023 and held it in 3 quarters. The position peaked at $141K in Q1 2024. 26 funds tracked by Wall St. Rank hold INAB as of Q2 2024.

  • Jim Simons reported no remaining IN8bio position as of Q2 2024 after selling out during the quarter.
  • Jim Simons sold 3,972 IN8bio shares in Q2 2024, an estimated $141K.
  • Jim Simons first reported a position in IN8bio in Q2 2023 and held it in 3 quarters.
  • Jim Simons's IN8bio position peaked at $141K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held IN8bio as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.